Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of rifampicin plus imipenem for severe nosocomial infections caused by multidrug-resistant Acinetobacter baumannii
2007-005268-29Phase 4Active
- Sponsor
- Hospital Universitario Virgen del Rocío
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of imipenem and rifampicin in pneumonia, Bacteremia and Complicated skin and skin structure infection (cSSSI), sponsored by Hospital Universitario Virgen del Rocío. Primary endpoint: Clinical response at end of treatment. Started Nov 2007; status: active.
02
Drugs
imipenemrifampicin
03
Conditions
pneumoniaBacteremiaComplicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on 2007-005268-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005268-29.